Suppr超能文献

骨膜蛋白对异丙肾上腺素诱导的缺血性损伤心肌细胞修复的积极作用:体外模型

Positive effect of Periostin on repair of Isopreternol induced ischemic damaged cardiomyocyte: an in vitro model.

作者信息

Edalati Saeideh, Khajeniazi Safoura

机构信息

Department of Medical Biotechnology, School of Advanced Medical Technology, Golestan University of Medical Sciences, Gorgan, Iran.

Stem Cell Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

出版信息

Regen Ther. 2022 Mar 19;20:26-31. doi: 10.1016/j.reth.2022.03.003. eCollection 2022 Jun.

Abstract

INTRODUCTION

One of the diseases in developed counties is myocardial infarction that causes the death of many people. A Problem of many new drugs usage concerns their assessment for applying therapeutically for heart disease. Previous studies used animal models but today many researchers tend to apply cellular models for feasibility of cellular model production and application.

METHODS

For this purpose, we differentiated human bone marrow mesenchymal stem cells (hBM-MDCs) into cardiomyocyte, then induced damage into cells by Isoproterenol, and finally we assayed repair of cardiomyocyte by Periostin. Damage induction and repair were confirmed by measurement of selected markers for cardiac damage and repair at mRNA level. In addition, we measured LDH activity in culture medium during damage and repair processes.

RESULTS

Our results showed LDHa and b mRNA levels increased and also cardiac markers decreased during damage of cardiomyocytes significantly. Reciprocally LDH isozymes decreased and cardiac markers increased during repair of cardiomyocytes.

DISCUSSION/CONCLUSION: These alterations in cardiac markers after Periostin treatment demonstrate that Periostin is an effective factor on repair of cardiomyocytes. LDH activity in culture medium decreases after damage induction and increases during repair process. According to our data, Isoproterenol and Periostin are good inducer to produce damaged and repaired differentiated cardiomyocytes respectively.

摘要

引言

发达国家的疾病之一是心肌梗死,它导致许多人死亡。许多新药使用的一个问题是它们在心脏病治疗应用中的评估。以前的研究使用动物模型,但如今许多研究人员倾向于应用细胞模型,因为细胞模型的制备和应用具有可行性。

方法

为此,我们将人骨髓间充质干细胞(hBM-MDCs)分化为心肌细胞,然后用异丙肾上腺素诱导细胞损伤,最后我们检测骨膜蛋白对心肌细胞的修复作用。通过在mRNA水平测量心脏损伤和修复的选定标志物来确认损伤诱导和修复。此外,我们在损伤和修复过程中测量了培养基中的乳酸脱氢酶(LDH)活性。

结果

我们的结果显示,在心肌细胞损伤期间,LDHa和b的mRNA水平升高,心脏标志物显著降低。相反,在心肌细胞修复期间,LDH同工酶降低,心脏标志物增加。

讨论/结论:骨膜蛋白治疗后心脏标志物的这些变化表明骨膜蛋白是心肌细胞修复的有效因子。损伤诱导后培养基中的LDH活性降低,修复过程中升高。根据我们的数据,异丙肾上腺素和骨膜蛋白分别是产生受损和修复的分化心肌细胞的良好诱导剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ac/8943212/6e41876d9474/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验